Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Innoviva (INVA) stocks in Canada
Learn how to easily invest in Innoviva stocks.
Innoviva is a biotechnology business based in the US. Innoviva stocks (INVA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $12.71 – a decrease of 1.92% over the previous week. Innoviva employs 5 staff and has a trailing 12-month revenue of around $374.7 million.
How to buy shares in Innoviva
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – INVA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Innoviva?
- Has coronavirus impacted Innoviva shares?
- Innoviva shares summary
- Compare share dealing platforms
- Is Innoviva stock a buy or sell?
- Innoviva performance over time
- Are Innoviva shares over-valued?
- Innoviva's financials
- How volatile are Innoviva shares?
- Does Innoviva pay a dividend?
- Have Innoviva shares ever split?
- Other common questions
Innoviva stock price (NASDAQ:INVA)Use our graph to track the performance of INVA stocks over time.
Innoviva shares at a glance
|Latest market close||$15.86|
|52-week range||$10.92 - $18.97|
|50-day moving average||$17.05|
|200-day moving average||$15.06|
|Wall St. target price||$10.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$3.07|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Innoviva stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Innoviva price performance over time
|1 week (2022-01-21)||-1.92%|
|1 month (2021-12-27)||-10.65%|
|3 months (2021-10-29)||-9.11%|
|6 months (2021-07-29)||12.48%|
|1 year (2021-01-29)||32.06%|
|2 years (2020-01-29)||13.12%|
|3 years (2019-01-29)||20.06|
|5 years (2017-01-27)||46.72%|
Is Innoviva under- or over-valued?
Valuing Innoviva stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Innoviva's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Innoviva's P/E ratio
Innoviva's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Innoviva shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Innoviva's PEG ratio
Innoviva's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.24. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Innoviva's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Innoviva's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $357.1 million.
The EBITDA is a measure of a Innoviva's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$374.7 million|
|Operating margin TTM||95.3%|
|Gross profit TTM||$335 million|
|Return on assets TTM||24.67%|
|Return on equity TTM||77.57%|
|Market capitalisation||$1.1 billion|
TTM: trailing 12 months
Innoviva share dividends
We're not expecting Innoviva to pay a dividend over the next 12 months.
Have Innoviva's shares ever split?
Innoviva's shares were split on a 1241:1000 basis on 2 June 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1241 shares. This wouldn't directly have changed the overall worth of your Innoviva shares – just the quantity. However, indirectly, the new 19.4% lower share price could have impacted the market appetite for Innoviva shares which in turn could have impacted Innoviva's share price.
Innoviva share price volatility
Over the last 12 months, Innoviva's shares have ranged in value from as little as $10.92 up to $18.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Innoviva's is 0.481. This would suggest that Innoviva's shares are less volatile than average (for this exchange).
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc.
Stocks similar to Innoviva
Innoviva in the news
Ackman takes a big stake in Netflix, excited about company's long-term prospects
First Quadrant L P Buys Innoviva Inc, NOW Inc, General Electric Co, Sells , Brookfield Asset ...
What to watch today: Stock futures turn positive, reversing big overnight losses
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.